102 Alternatively, quite a few groups are advocating for that incorporation of novel markers, such as a intricate karyotype55 or epigenetic subsets, 27,28 into scientific practice. Each one of these novel prognostic and/or predictive designs will must be validated in cohorts of people handled with s